在60岁以上的骨髓质综合征患者中出现的二次急性髓白血病
Dipabali Chaudhuri1, Kokab Irfan Khan1, Roba Al Shouli2
1Research, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Cureus
|July 10, 2023
概括
骨髓发育综合征 (MDS) 治疗侧重于向分子突变,以防止进展为急性髓性白血病 (AML). 个性化药物组合和干细胞移植为MDS患者提供潜在的缓解或治疗.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 骨髓质疏松症候群 (MDS) 涉及血液形成干细胞中的瘤细胞,导致发育不良和潜在的细胞衰减.
- 大发性多发性硬化主要影响60岁以上的人,并且可以发展为二次急性髓性白血病 (AML),预后较差.
- 有效的MDS管理对于预防AML发展和改善患者的治疗结果至关重要.
研究的目的:
- 审查目前MDS的治疗策略,重点是实现缓解和预防AML的进展.
- 探索分子突变在MDS发病过程中的作用及其对治疗选择的影响.
- 评估向疗法和全原干细胞移植在管理MDS时的疗效.
主要方法:
- 对与MDS和二次AML相关的分子突变的审查.
- 基于特定突变的化疗剂和向药物的分析.
- 评估全源干细胞移植的可行性和移植后恢复策略.
主要成果:
- 分子突变在MDS中显著影响治疗选择和药物疗效.
- 针对性治疗对于解决特定突变和克服耐药性至关重要.
- 同源干细胞移植为MDS提供了潜在的治疗方法,目前正在研究优化恢复.
结论:
- 个性化治疗方法,利用基于个体突变特征的量身定制药物组合,是管理MDS和二次AML的最佳方法.
- 针对特定的分子异常可以改善治疗结果,并增加MDS患者的整体存活率.
- 需要进一步的研究来完善干细胞移植方案,并尽量减少相关的并发症.
相关概念视频
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...